Christian Waage — SEC Form 4 filings
SEC reporting owner CIK 1553179. 10 Form 4 filings on record with FilingPulse; latest filed 2026-08-26.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-01-19 to 2026-08-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 6,430 shares, $7,430 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 32.
- Largest priced transaction: sale of 6,430 shares @ $1.16 ($7,430) in Gossamer Bio, Inc., filed 2024-03-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | EVP, Tech Ops and Admin | 6 | — | 1 leg · 6,430 sh · $7,430 | 25 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | Director | 4 | — | — | 7 |
Form 4 filings — Christian Waage
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-26 | 4 | Gossamer Bio, Inc. (GOSS) | Grant/award (A): 2,900,026 (derivative) @ $0 | EDGAR |
| 2026-03-20 | 4 | Gossamer Bio, Inc. (GOSS) | Disposition to issuer (D): 506,250 (derivative) · Disposition to issuer (D): 440,000 (derivative) · Disposition to issuer (D): 375,000 (derivative) · Disposition to issuer (D): 125,000 (derivative) · Disposition to issuer (D): 157,500 (derivative) · Disposition to issuer (D): 157,500 (derivative) · +14 more | EDGAR |
| 2026-02-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 53,960 @ $0 | EDGAR |
| 2026-01-05 | 4 | Gossamer Bio, Inc. (GOSS) | Grant/award (A): 84,500 @ $0 · Grant/award (A): 506,250 (derivative) @ $0 | EDGAR |
| 2025-10-02 | 4 | Gossamer Bio, Inc. (GOSS) | Grant/award (A): 125,000 @ $0 | EDGAR |
| 2025-03-06 | 4 | Gossamer Bio, Inc. (GOSS) | Grant/award (A): 440,000 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4/A | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 17,950 @ $0 · Grant/award (A): 35,900 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 17,950 @ $0 · Grant/award (A): 35,900 (derivative) @ $1.73 | EDGAR |
| 2024-03-28 | 4 | Gossamer Bio, Inc. (GOSS) | Sale (S): 6,430 @ $1.16 | EDGAR |
| 2024-01-19 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 13,948 @ $0 · Grant/award (A): 83,685 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1553179 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →